Clinical Trials in Chicago

Showing 16381-16400 of 20,493 trials

AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors

NCT00326664

This phase I trial is studying the side effects and best dose of AZD2171 in treating young patients with recurrent, progressive, or refractory primary CNS tumors. AZD2171 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor.

Childhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System Germ Cell TumorChildhood Cerebral Anaplastic Astrocytoma+18 more

National Cancer Institute (NCI)55 participantsStarted Mar 2006

San Francisco, California, United States • Washington D.C., District of Columbia, United States • Chicago, Illinois, United States +8 more locations

COMPLETEDPhase 22.2 miles

Clinical Study of BYM338 for the Treatment of Unintentional Weight Loss in Patients With Cancer of the Lung or the Pancreas

NCT01433263

A safety \& efficacy clinical study of the investigational medicinal product BYM338 for the treatment of unintentional weight loss in patients with cancer of the lung or the pancreas

Cachexia

Novartis Pharmaceuticals57 participantsStarted Aug 2011

Tucson, Arizona, United States • Tampa, Florida, United States • Chicago, Illinois, United States +7 more locations

AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors

Clinical Study of BYM338 for the Treatment of Unintentional Weight Loss in Patients With Cancer of the Lung or the Pancreas

Find Trials by Condition in Chicago

Intradiscal rhGDF-5 Phase I/II Clinical Trial

Randomized Controlled Trial of Antibiotics in the Management of Children With Community-Acquired Abscess

Comparing Outcomes of Elbow Extension Tendon Transfers

Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC)

An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age

A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Enrolled in a Methadone Maintenance Treatment Program.

Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma

Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Internet-based Interacting Together Everyday, Recovery After Childhood TBI (I-InTERACT)--RRTC

A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel

Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents

Glucose Meter Study

Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Early Alzheimer's Disease

Pharmacogenetics of Nicotine Addiction Treatment

ProMRI PROVEN Master Study

Sorafenib and Topotecan in Refractory/Recurrent Pediatric Malignancies

Ph 1 Trial of ADI PEG 20 Plus Sorafenib to Treat Patients With Liver Cancer

Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients